Taike Biotechnology
Taike Biotechnology Co., Ltd., commonly referred to as Taike Bio, is a leading player in the biotechnology industry, headquartered in China. Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative solutions in biopharmaceuticals and diagnostics. Taike Bio is renowned for its cutting-edge products, including monoclonal antibodies and recombinant proteins, which are distinguished by their high specificity and efficacy. The company has achieved significant milestones, including numerous patents and collaborations with research institutions, solidifying its position in the competitive biotech landscape. With a commitment to advancing healthcare through biotechnology, Taike Bio continues to make notable contributions, enhancing its reputation as a trusted provider of high-quality biotechnological products and services.
DitchCarbon Score
How does Taike Biotechnology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Taike Biotechnology's score of 10 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Taike Biotechnology's reported carbon emissions
In 2023, Taike Biotechnology reported total carbon emissions of approximately 116,975 kg CO2e from Scope 2 and 5,280 kg CO2e from Scope 3, specifically related to waste generated in operations. This marks a significant reduction from 2022, where emissions were about 138,685 kg CO2e for Scope 2 and 7,920 kg CO2e for Scope 3. The company has demonstrated a commitment to reducing its carbon footprint, particularly in Scope 2 emissions, which saw a decrease of approximately 21,710 kg CO2e year-on-year. However, there are currently no documented reduction targets or climate pledges outlined by Taike Biotechnology. Overall, Taike Biotechnology's efforts reflect a proactive approach to managing carbon emissions, aligning with industry standards for climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 138,685 | 000,000 |
| Scope 3 | 7,920 | 0,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Taike Biotechnology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
